Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 15/20 | 0.41 |
| ▸ | PPARG | P37231 | 14/20 | 0.41 |
| ▸ | PPARD | Q03181 | 14/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
| ▸ | PDE5A | O76074 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5208484 | 0.98 | PPARD (0.39) | PPARAPPARGPPARDGRM2NR1H2 | |
| SCHEMBL5211567 | 0.88 | PPARA (0.43) | PPARAPPARGPPARDPDE5A | |
| SCHEMBL7663368 | 0.84 | PPARA (0.40) | PPARAPPARGPPARDGRM2NR1H2 | |
| SCHEMBL7670010 | 0.84 | PPARA (0.40) | PPARAPPARGPPARDGRM2NR1H2 | |
| SCHEMBL7458629 | 0.78 | PPARA (0.49) | PPARAPPARGPPARDGRM2 | |
| SCHEMBL5208431 | 0.77 | PPARG (0.57) | PPARAPPARGPPARD | |
| SCHEMBL7459290 | 0.76 | PPARG (0.40) | PPARAPPARGPPARDGRM2NR1H2 | |
| SCHEMBL5205168 | 0.76 | PPARA (0.52) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL5211391 | 0.76 | PPARG (0.40) | PPARAPPARGPPARD | |
| SCHEMBL7663361 | 0.75 | PPARG (0.40) | PPARAPPARGPPARDGRM2NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1040102-B1 | ARYLTHIAZOLIDINEDIONE DERIVATIVES | MERCK & CO INC (US) | 2007-01-24 | — | — | EP | disclosed |
| US-6399640-B1 | ANTIDIABETIC AGENTS; ANTICHOLESTEROL AGENTS | MERCK & CO., INC. | 2002-06-04 | — | — | US | disclosed |
| US-6200998-B1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS; ANTICHOLESTEROL, ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. | 2001-03-13 | — | — | US | disclosed |
| US-6008237-A | POTENT AGONISTS OF PEROXIDSOME PROLIFERATOR ACTIVATED RECEPTOR; FOR CONTROLLING OR PREVENTING OF DIABETES, HYPERGLYCEMIA, HYPERLIPIDEMIA, HYPERCHOLESTEROLEMIA, ATHEROSCLEROSIS, OBESITY, VASCULAR RESTENOSIS | MERCK & CO., INC. (US) | 1999-12-28 | — | — | US | disclosed |